Reslizumab: add‐on therapy for severe eosinophilic asthma [PDF]
, 2017 Steve Chaplin
openalex +1 more source
PRS10 COST-UTILITY ANALYSIS OF MEPOLIZUMAB VERSUS BENRALIZUMAB FOR SEVERE EOSINOPHILIC ASTHMA IN THE COLOMBIAN HEALTHCARE SYSTEM [PDF]
, 2020 Elena Vázquez Rodríguez +1 more
openalex +1 more source
Synergistic activation of pro-inflammatory type-2 CD8+ T lymphocytes by lipid mediators in severe eosinophilic asthma [PDF]
, 2018 Bart Hilvering +25 more
openalex +1 more source
Regulatory T cell monitoring in severe eosinophilic asthma patients treated with mepolizumab [PDF]
, 2021 Laura Bergantini +10 more
openalex +1 more source
Exercise Recommendations and Practical Considerations for Asthma Management—An EAACI Position Paper
Allergy, EarlyView.ABSTRACT Exercise is an important treatment for people with asthma and should be considered alongside pharmacological therapy when developing personalised asthma management plans. Despite this, there remains limited guidance concerning the practicalities of asthma‐specific exercise prescription.
Oliver J. Price +13 more
wiley +1 more source
Determining Health Utilities through Data Mining of Social Media [PDF]
arXiv, 2016 'Health utilities' measure patient preferences for perfect health compared to specific unhealthy states, such as asthma, a fractured hip, or colon cancer. When integrated over time, these estimations are called quality adjusted life years (QALYs). Until now, characterizing health utilities (HUs) required detailed patient interviews or written surveys ...
arxiv
Drug Design, Development and Therapy, 2017 Corrado Pelaia,1 Alessandro Vatrella,2 Maria Teresa Busceti,1 Luca Gallelli,3 Rosa Terracciano,3 Rocco Savino,3 Girolamo Pelaia1 1Department of Medical and Surgical Sciences, Section of Respiratory Diseases, University “Magna Græcia&rdquo ...
Pelaia C +6 more
doaj
Respiratory Medicine Case Reports, 2022 Severe eosinophilic asthma is associated with a high corticosteroid burden, particularly in patients with comorbid chronic sinusitis/nasal polyps. This case study reports a 33-year-old woman who presented to the severe asthma center with uncontrolled ...
Adel H. Mansur, PhD FRCP
doaj
Baseline blood eosinophil count as a predictor of treatment response to the licensed dose of mepolizumab in severe eosinophilic asthma [PDF]
, 2019 Frank C. Albers +7 more
openalex +1 more source
Clinical Experience in the Treatment of Severe Eosinophilic Asthma With Mepolizumab [PDF]
, 2020 Ana Isabel Enríquez Rodríguez +14 more
openalex +1 more source